News
- Author:
- Heidi Splete
Publish date: August 8, 2023
Frailty progression was significantly accelerated in patients with PRISm and COPD.
News
- Author:
- Heidi Splete
Publish date: August 8, 2023
Responders to lithium for BPD were less likely than nonresponders to be of African ancestry, and more likely of European ancestry.
News
- Author:
- Heidi Splete
Publish date: August 8, 2023
Patients hospitalized with severe exacerbations of ECOPD are at increased risk for worse clinical outcomes and death.
News
- Author:
- Heidi Splete
Publish date: August 7, 2023
Patients randomized to dural epidural also showed a higher quality of epidural blockade for surgical delivery.
News
- Author:
- Heidi Splete
Publish date: August 3, 2023
Lower doses of initial vasopressin were associated with lower mortality.
News
- Author:
- Heidi Splete
Publish date: August 3, 2023
Bronchoalveolar lavage was s stronger contributor to diagnosis in nonneutropenic patients.
News
- Author:
- Heidi Splete
Publish date: August 2, 2023
Data from a large cohort study also showed an increase in risk for aortic stenosis–related interventions and death.
News
- Author:
- Heidi Splete
Publish date: July 28, 2023
Body composition and cardiorespiratory fitness improved with a combination of aerobic and resistance exercise.
News
- Author:
- Heidi Splete
Publish date: July 26, 2023
Age at diagnosis may have potential as a screening tool for unaffected relatives of familial pulmonary fibrosis patients.
News
- Author:
- Heidi Splete
Publish date: July 24, 2023
The protective effect of primary care was similar for Black and White patients up to 180 days.
News
- Author:
- Heidi Splete
Publish date: July 19, 2023
Declines in verbal working memory were observed 2 months before a relapse in multiple models.
News
- Author:
- Heidi Splete
Publish date: July 19, 2023
Ethnicity and auscultatory findings were factors predicting response; data may improve antibiotic stewardship.
News
- Author:
- Heidi Splete
Publish date: July 13, 2023
Large matched cohort study suggests stronger safety and effectiveness outcomes with LAMA-LABA inhalers vs. ICS-LABA inhalers.
News
- Author:
- Heidi Splete
Publish date: July 13, 2023
PRISm occurs in approximately 10% of the general population and has been identified as a predictor of adverse health outcomes.
News
- Author:
- Heidi Splete
Publish date: June 28, 2023
Genetic data also showed increased prevalence of certain mutations in early-onset patients.
